INTRODUCTION: One important concern during the management of COVID-19 pneumonia patients with acute hypoxemic respiratory failure is early anticipation of the need for intubation. ROX is an index that can help in identification of patients with low and those with high risk of intubation. So, this study was planned to validate the diagnostic accuracy of the ROX index for prediction of COVID-19 pneumonia outcome (the need for intubation) and, in addition, to underline the significant association of the ROX index with clinical, radiological, demographic data. MATERIAL AND METHODS: Sixty-nine RT-PCR positive COVID-19 patients were enrolled. The following data were collected: medical history, clinical classification of COVID-19 infection, the ROX index measured daily and the outcome assessment. RESULTS: All patients with severe COVID-19 infection (100%) were intubated (50% of them on the 3rd day of admission), but only 38% of patients with moderate COVID-19 infection required intubation (all of them on the 3rd day of admission). The ROX index on the 1st day of admission was significantly associated with the presence of comorbidities, COVID-19 clinical classification, CT findings and intubation (p ≤ 0.001 for each of them). Regression analysis showed that sex and ROX.1 are the only significant independent predictors of intubation [AOR (95% CI): 16.9 (2.4- 117), 0.77 (0.69-0.86)], respectively. Cut-off point of the ROX index on the 1st day of admission was ≤ 25.26 (90.2% of sensitivity and 75% of specificity). CONCLUSIONS: ROX is a simple noninvasive promising tool for predicting discontinuation of high-flow oxygen therapy and could be used in the assessment of progress and the risk of intubation in COVID-19 patients with pneumonia.
INTRODUCTION: One important concern during the management of COVID-19 pneumoniapatients with acute hypoxemic respiratory failure is early anticipation of the need for intubation. ROX is an index that can help in identification of patients with low and those with high risk of intubation. So, this study was planned to validate the diagnostic accuracy of the ROX index for prediction of COVID-19 pneumonia outcome (the need for intubation) and, in addition, to underline the significant association of the ROX index with clinical, radiological, demographic data. MATERIAL AND METHODS: Sixty-nine RT-PCR positive COVID-19patients were enrolled. The following data were collected: medical history, clinical classification of COVID-19infection, the ROX index measured daily and the outcome assessment. RESULTS: All patients with severe COVID-19infection (100%) were intubated (50% of them on the 3rd day of admission), but only 38% of patients with moderate COVID-19infection required intubation (all of them on the 3rd day of admission). The ROX index on the 1st day of admission was significantly associated with the presence of comorbidities, COVID-19 clinical classification, CT findings and intubation (p ≤ 0.001 for each of them). Regression analysis showed that sex and ROX.1 are the only significant independent predictors of intubation [AOR (95% CI): 16.9 (2.4- 117), 0.77 (0.69-0.86)], respectively. Cut-off point of the ROX index on the 1st day of admission was ≤ 25.26 (90.2% of sensitivity and 75% of specificity). CONCLUSIONS:ROX is a simple noninvasive promising tool for predicting discontinuation of high-flow oxygen therapy and could be used in the assessment of progress and the risk of intubation in COVID-19patients with pneumonia.
Authors: Filippo Cattazzo; Francesco Inglese; Andrea Dalbeni; Salvatore Piano; Martino Francesco Pengo; Martina Montagnana; Davide Dell'Atti; Francesco Soliani; Andrea Cascella; Stefano Vicini; Carmine Gambino; Pietro Minuz; Roberto Vettor; Gianfranco Parati; Paolo Angeli; Cristiano Fava Journal: Intern Emerg Med Date: 2022-01-28 Impact factor: 5.472
Authors: Carlos Fernando Valencia; Oscar David Lucero; Onofre Casas Castro; Andrey Alexandrovich Sanko; Peter Alfonso Olejua Journal: Sci Rep Date: 2021-11-19 Impact factor: 4.379
Authors: Miguel Ibarra-Estrada; Jie Li; Stephan Ehrmann; John G Laffey; Ivan Pavlov; Yonatan Perez; Oriol Roca; Elsa Tavernier; Bairbre McNicholas; David Vines; Miguel Marín-Rosales; Alexandra Vargas-Obieta; Roxana García-Salcido; Sara A Aguirre-Díaz; José A López-Pulgarín; Quetzalcóatl Chávez-Peña; Julio C Mijangos-Méndez; Guadalupe Aguirre-Avalos Journal: Crit Care Date: 2022-03-28 Impact factor: 9.097
Authors: Nicholas Russell Plummer; Andrew Fogarty; Dominick Shaw; Timothy Card; Joe West; Colin Crooks Journal: Respir Med Date: 2022-04-26 Impact factor: 4.582
Authors: Jin Hyoung Kim; Ae-Rin Baek; Song-I Lee; Won-Young Kim; Yong Sub Na; Bo Young Lee; Gil Myeong Seong; Moon Seong Baek Journal: PLoS One Date: 2022-05-12 Impact factor: 3.240